APLMW (Apollomics) Net Margin %: 0.00% (As of Dec. 2025)


APLMW Apollomics Inc APLMW
31 GF Score
Price $0.01
! 5 Warning Signs
View Full Analysis

What is Apollomics Net Margin %?

Apollomics APLMW -7.91% 31 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates APLMW with a GF Score™ of 31/100. The stock has 5 warning signs investors should review. Among 947 Biotechnology companies, Apollomics ranks worse than 53.96% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Apollomics's Net Income for the six months ended in Dec. 2025 was $1.60 Mil. Apollomics's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Apollomics's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Apollomics's Net Margin % or its related term are showing as below:

APLMW' s Net Margin % Range Over the Past 10 Years
Min: -128.69   Med: -128.69   Max: -128.69
Current: -128.69

APLMW's Net Margin % is ranked worse than
53.96% of 947 companies
in the Biotechnology industry
Industry Median: -89.56 vs APLMW: -128.69

Apollomics  (NAS:APLMW) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Apollomics Net Margin % Related Terms

Apollomics Net Margin % Historical Data

* Premium members only.

The historical data trend for Apollomics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollomics Net Margin % Chart

Apollomics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -128.69

Apollomics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -147.48 0.00

APLMW vs TVRD, PLRZ, LSTA: Net Margin % Comparison

For the Biotechnology subindustry, Apollomics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollomics Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apollomics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Apollomics's Net Margin % falls into.


APLMW
31GF Score
Apollomics Inc APLMW
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apollomics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Apollomics's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-10.939/8.5
=-128.69 %

Apollomics's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=1.597/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Apollomics (APLMW) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Apollomics and its competitors. According to the industry distribution chart, Apollomics ranks #511 out of 947 companies in the Biotechnology industry, placing it in the top 54%.
Is Apollomics' Net Margin % too high?
Apollomics' current Net Margin % is 0.00%. Based on the distribution chart, Apollomics ranks #511 out of 947 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Apollomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Apollomics' Net Margin % compare to TVRD and PLRZ?
According to the Biotechnology industry distribution chart, Apollomics ranks #511 out of 947 companies for Net Margin %. This places Apollomics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Apollomics and its competitors. Apollomics's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollomics stock overvalued right now?
Apollomics (APLMW) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Apollomics' overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Apollomics (APLMW), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apollomics Business Description

Other Exchanges APLM:USA
Address 989 East Hillsdale Boulevard, Suite 220, Foster, CA, USA, 94404
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
31GF Score

Get the complete analysis for APLMW

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price